摘要
目的:探讨急性冠脉综合征(ACS)经皮冠状动脉介入治疗(PCI)患者术后用药期间应用医护药一体化延续干预的效果。方法:选取河南省胸科医院2022年1月—2022年12月100例PCI术后ACS患者作为研究对象,按照随机数字表法分为对照组(n=50)和观察组(n=50)。对照组给予常规延续性照顾干预,观察组在对照组基础上给予医护药一体化延续干预,观察两组疾病危险因素控制情况、服药依从性、不良心血管事件发生情况。结果:观察组高血糖、高低密度脂蛋白胆固醇(LDL-C)、高血压控制率均高于对照组(P<0.05);观察组服药依从率高于对照组(P<0.05);观察组不良心血管事件发生率低于对照组(P<0.05)。结论:ACS PCI患者术后用药期间应用医护药一体化延续干预可以有效提高疾病危险因素控制率和服药依从性,减少不良心血管事件的发生。
Objective:To explore the effect of continuous intervention of integrated medical care and medicine in patients with acute coronary syndrome(ACS)undergoing percutaneous coronary intervention(PCI)during postoperative medication.Methods:A total of 100 ACS patients after PCI in Henan Chest Hospital from January 2022 to December 2022 were selected as the research objects.According to the random number table method,they were divided into control group(n=50)and observation group(n=50).The control group was given routine continuous care intervention,and the observation group was given integrated continuous intervention of medical care and medicine on the basis of the control group.The control of disease risk factors,medication compliance and adverse cardiovascular events were observed in the two groups.Results:The control rate of hyperglycemia,high and low density lipoprotein cholesterol(LDL-C)and hypertension were higher in the observation group(P<0.05).The medication adherence rate was higher than the control group(P<0.05).The incidence of adverse cardiovascular events was lower than that in the control group(P<0.05).Conclusion:The application of integrated continuous intervention of medical care and medicine in ACS PCI patients during postoperative medication can effectively improve the control rate of disease risk factors and medication compliance,and reduce the occurrence of adverse cardiovascular events.
作者
巩晓旸
孔深柯
王雅茹
王焕东
GONG Xiaoyang;KONG Shenke;WANG Yaru;WANG Huandong(Department of Emergency,Henan Chest Hospital of Zhengzhou University,Zhengzhou 450000,Henan,China;Department of Cardiology,Henan Chest Hospital of Zhengzhou University,Zhengzhou 450000,Henan,China)
出处
《中国药物滥用防治杂志》
CAS
2024年第3期474-477,483,共5页
Chinese Journal of Drug Abuse Prevention and Treatment
基金
河南省医学科技攻关计划联合共建项目(编号:LHGJ20190730)。
关键词
急性冠脉综合征
经皮冠状动脉介入治疗
延续性护理
医护药一体化
Acute coronary syndrome
Percutaneous coronary intervention
continuous care
Integration of medical medicine
